[
    {
        "smiles": "NC1=NC=NC2=C1N=CN2[C@@H]1C=C[C@H](O)[C@H]1O",
        "id": "DB03216",
        "molecule": "(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",
        "iupac_name": "(1S,2S,5R)-5-(6-amino-9H-purin-9-yl)cyclopent-3-ene-1,2-diol",
        "inchi": {
            "hash": "RQPALADHFYHEHK-CHKWXVPMSA-N",
            "id": "InChI=1S/C10H11N5O2/c11-9-7-10(13-3-12-9)15(4-14-7)5-1-2-6(16)8(5)17/h1-6,8,16-17H,(H2,11,12,13)/t5-,6+,8+/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 233.2266,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 233.091274621,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as 1,3-substituted cyclopentyl purine nucleosides. These are nucleoside analogues with a structure that consists of a cyclobutane that is substituted a the 1-position with a hydroxyl group and at the 3-position with either a purine base.",
        "link": "https://go.drugbank.com/drugs/DB03216",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UAdenosylhomocysteinase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CN1C=CN=C1C(=O)C1=C(C)C2=C(O1)C=CC=C2OCCCNCC1=CN=CC=C1",
        "id": "DB03062",
        "molecule": "(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone",
        "iupac_name": "(3-{[3-methyl-2-(1-methyl-1H-imidazole-2-carbonyl)-1-benzofuran-4-yl]oxy}propyl)[(pyridin-3-yl)methyl]amine",
        "inchi": {
            "hash": "VZBQJKIOAOUYJL-UHFFFAOYSA-N",
            "id": "InChI=1S/C23H24N4O3/c1-16-20-18(29-13-5-10-25-15-17-6-4-9-24-14-17)7-3-8-19(20)30-22(16)21(28)23-26-11-12-27(23)2/h3-4,6-9,11-12,14,25H,5,10,13,15H2,1-2H3"
        },
        "weight": [
            {
                "type": "average",
                "weight": 404.4617,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 404.184840654,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as benzofurans. These are organic compounds containing a benzene ring fused to a furan. Furan is a five-membered aromatic ring with four carbon atoms and one oxygen atom.",
        "link": "https://go.drugbank.com/drugs/DB03062",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGlycylpeptide N-tetradecanoyltransferase 1"
            },
            {
                "action": "Not Available",
                "organism": "Yeast",
                "target": "UGlycylpeptide N-tetradecanoyltransferase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "OC(CC1=CC=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O",
        "id": "DB07409",
        "molecule": "(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",
        "iupac_name": "(1-hydroxy-2-{4'-phenyl-[1,1'-biphenyl]-3-yl}-1-phosphonoethyl)phosphonic acid",
        "inchi": {
            "hash": "MPBUFKZCEBTBSK-UHFFFAOYSA-N",
            "id": "InChI=1S/C20H20O7P2/c21-20(28(22,23)24,29(25,26)27)14-15-5-4-8-19(13-15)18-11-9-17(10-12-18)16-6-2-1-3-7-16/h1-13,21H,14H2,(H2,22,23,24)(H2,25,26,27)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 434.3161,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 434.068426018,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as p-terphenyls. These are terphenyls with a structure containing the 1,4-diphenylbenzene skeleton.",
        "link": "https://go.drugbank.com/drugs/DB07409",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Escherichia coli (strain K12)",
                "target": "UDitrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@@H](C1)C(C)=C",
        "id": "DB18097",
        "molecule": "(-)-beta-Elemene",
        "cas": "515-13-9",
        "inchi": {
            "hash": "OPFTUNCRGUEPRZ-QLFBSQMISA-N",
            "id": "InChI=1S/C15H24/c1-7-15(6)9-8-13(11(2)3)10-14(15)12(4)5/h7,13-14H,1-2,4,8-10H2,3,5-6H3/t13-,14+,15+/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 204.357,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 204.187800773,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB18097",
        "type": "Small Molecule",
        "synonyms": [
            ".beta.-elemene",
            "(-)-.beta.-elemene",
            "(-)-B-elemene",
            "(-)-beta-Elemene",
            "Cyclohexane",
            "1-ethenyl-1-methyl-2",
            "4-bis(1-methylethenyl)-",
            "(1s",
            "2s",
            "4r)-",
            "Elemene",
            "(-)-.beta.-"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "O\\N=C1/CCC2=CC(=CC=C12)C1=CN(N=C1C1=CC=NC=C1)C1CCNCC1",
        "id": "DB08553",
        "molecule": "(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",
        "iupac_name": "N-[(1E)-5-[1-(piperidin-4-yl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl]-2,3-dihydro-1H-inden-1-ylidene]hydroxylamine",
        "background": "(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1h-pyrazol-4-yl)-2,3-dihydro-1h-inden-1-one oxime is a solid. This compound belongs to the phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. It targets the protein serine/threonine-protein kinase B-raf.\n",
        "inchi": {
            "hash": "KWEFZSZCLBHIEQ-YYADALCUSA-N",
            "id": "InChI=1S/C22H23N5O/c28-26-21-4-2-16-13-17(1-3-19(16)21)20-14-27(18-7-11-24-12-8-18)25-22(20)15-5-9-23-10-6-15/h1,3,5-6,9-10,13-14,18,24,28H,2,4,7-8,11-12H2/b26-21+"
        },
        "weight": [
            {
                "type": "average",
                "weight": 373.4509,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 373.190260383,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as indanes. These are compounds containing an indane moiety, which consists of a cyclopentane fused to a benzene ring.",
        "link": "https://go.drugbank.com/drugs/DB08553",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "USerine/threonine-protein kinase B-raf"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@@]1(C)CNC2=C(SC3=C2C2=C(C=C3)N=C(C=C2)C2=CN=C(C)C=C2)C(=O)N1",
        "id": "DB07430",
        "molecule": "(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",
        "iupac_name": "(15R)-15-methyl-5-(6-methylpyridin-3-yl)-11-thia-6,14,17-triazatetracyclo[8.8.0.0^{2,7}.0^{12,18}]octadeca-1(10),2(7),3,5,8,12(18)-hexaen-13-one",
        "inchi": {
            "hash": "CMWRPDHVGMHLSZ-GFCCVEGCSA-N",
            "id": "InChI=1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 374.459,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 374.120131908,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as bipyridines and oligopyridines. These are organic compounds containing two pyridine rings linked to each other.",
        "link": "https://go.drugbank.com/drugs/DB07430",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UMAP kinase-activated protein kinase 2"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC(C)[C@H]1CC[C@H](C)C[C@@H]1O",
        "id": "DB11344",
        "molecule": "(+)-menthol",
        "cas": "15356-60-2",
        "iupac_name": "(1S,2R,5S)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol",
        "inchi": {
            "hash": "NOOLISFMXDJSKH-AEJSXWLSSA-N",
            "id": "InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 156.269,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 156.151415264,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as menthane monoterpenoids. These are monoterpenoids with a structure based on the o-, m-, or p-menthane backbone. P-menthane consists of the cyclohexane ring with a methyl group and a (2-methyl)-propyl group at the 1 and 4 ring position, respectively. The o- and m- menthanes are much rarer, and presumably arise by alkyl migration of p-menthanes.",
        "link": "https://go.drugbank.com/drugs/DB11344",
        "type": "Small Molecule",
        "synonyms": [
            "(+)-(1S",
            "2R",
            "5S)-menthol",
            "(+)-(1S",
            "3S",
            "4R)-menthol",
            "(1S",
            "2R",
            "5S)-(+)-menthol",
            "(1S",
            "2R",
            "5S)-menthol",
            "D-menthol"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CN1C=CN=C1C(=O)C1=C(C)C2=C(O1)C=CC=C2OCCCNCC1=CN=CC=C1",
        "id": "DB03062",
        "molecule": "(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone",
        "iupac_name": "(3-{[3-methyl-2-(1-methyl-1H-imidazole-2-carbonyl)-1-benzofuran-4-yl]oxy}propyl)[(pyridin-3-yl)methyl]amine",
        "inchi": {
            "hash": "VZBQJKIOAOUYJL-UHFFFAOYSA-N",
            "id": "InChI=1S/C23H24N4O3/c1-16-20-18(29-13-5-10-25-15-17-6-4-9-24-14-17)7-3-8-19(20)30-22(16)21(28)23-26-11-12-27(23)2/h3-4,6-9,11-12,14,25H,5,10,13,15H2,1-2H3"
        },
        "weight": [
            {
                "type": "average",
                "weight": 404.4617,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 404.184840654,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as benzofurans. These are organic compounds containing a benzene ring fused to a furan. Furan is a five-membered aromatic ring with four carbon atoms and one oxygen atom.",
        "link": "https://go.drugbank.com/drugs/DB03062",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGlycylpeptide N-tetradecanoyltransferase 1"
            },
            {
                "action": "Not Available",
                "organism": "Yeast",
                "target": "UGlycylpeptide N-tetradecanoyltransferase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "COC1=CC2=C(C=C1)N(CC1=CC=CC=C1)C(C)=C2CC(O)=O",
        "id": "DB03121",
        "molecule": "(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid",
        "cas": "59283-35-1",
        "iupac_name": "2-(1-benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid",
        "inchi": {
            "hash": "ZEKCBTQHDTUHRJ-UHFFFAOYSA-N",
            "id": "InChI=1S/C19H19NO3/c1-13-16(11-19(21)22)17-10-15(23-2)8-9-18(17)20(13)12-14-6-4-3-5-7-14/h3-10H,11-12H2,1-2H3,(H,21,22)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 309.3591,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 309.136493479,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole.",
        "link": "https://go.drugbank.com/drugs/DB03121",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UPhospholipase A2, membrane associated"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C([3H])C([3H])C2=CC(=O)C([3H])C([3H])[C@]12C",
        "id": "DB14093",
        "molecule": "(1,2,6,7-3H)Testosterone",
        "cas": "67308-98-9",
        "iupac_name": "(1S,3aS,3bR,9aR,9bS,11aS)-1-hydroxy-9a,11a-dimethyl(4,5,8,9-3H4)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",
        "inchi": {
            "hash": "MUMGGOZAMZWBJJ-JQSYSRDDSA-N",
            "id": "InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1/i3T,4T,7T,9T/t3?,4?,7?,9?,14-,15-,16-,17-,18-,19-"
        },
        "weight": [
            {
                "type": "average",
                "weight": 296.463,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 296.241827085,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB14093",
        "type": "Small Molecule",
        "synonyms": [
            "Testosterone",
            "1",
            "2",
            "6",
            "7-H-3"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\nAbciximab(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Abciximab.Acenocoumarol(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Acenocoumarol.Alteplase(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Alteplase.Ancrod(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Ancrod.Anistreplase(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Anistreplase.Antithrombin Alfa(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Antithrombin Alfa.Antithrombin III human(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Antithrombin III human.Apixaban(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Apixaban.Ardeparin(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Ardeparin.Argatroban(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Argatroban.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   "
    },
    {
        "smiles": "CCCCCCCCC(O)(P(O)(O)=O)P(O)(O)=O",
        "id": "DB06931",
        "molecule": "(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",
        "iupac_name": "(1-hydroxy-1-phosphonononyl)phosphonic acid",
        "inchi": {
            "hash": "COHUUYPEYRMWTH-UHFFFAOYSA-N",
            "id": "InChI=1S/C9H22O7P2/c1-2-3-4-5-6-7-8-9(10,17(11,12)13)18(14,15)16/h10H,2-8H2,1H3,(H2,11,12,13)(H2,14,15,16)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 304.2143,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 304.084076082,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms.",
        "link": "https://go.drugbank.com/drugs/DB06931",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGeranylgeranyl pyrophosphate synthase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC[C@@H](C1=CC(NC(=O)CNC(=O)OC(C)(C)C)=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O",
        "id": "DB08664",
        "molecule": "({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester",
        "iupac_name": "tert-butyl N-[({3-[(1S)-1-(4-hydroxy-2-oxo-2H-chromen-3-yl)propyl]phenyl}carbamoyl)methyl]carbamate",
        "inchi": {
            "hash": "QUQQVMVIWCUYFV-KRWDZBQOSA-N",
            "id": "InChI=1S/C25H28N2O6/c1-5-17(21-22(29)18-11-6-7-12-19(18)32-23(21)30)15-9-8-10-16(13-15)27-20(28)14-26-24(31)33-25(2,3)4/h6-13,17,29H,5,14H2,1-4H3,(H,26,31)(H,27,28)/t17-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 452.4996,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 452.194736638,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as 4-hydroxycoumarins. These are coumarins that contain one or more hydroxyl groups attached to C4-position the coumarin skeleton.",
        "link": "https://go.drugbank.com/drugs/DB08664",
        "type": "Small Molecule",
        "synonyms": [
            "tert-butyl N-[({3-[(1S)-1-(4-hydroxy-2-oxo-2H-chromen-3-yl)propyl]phenyl}carbamoyl)methyl]carbamate"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "HIV-2",
                "target": "UGag-Pol polyprotein"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@]1(CC#N)CC[C@@]2([H])[C@]3([H])CCC4=CC(OS(N)(=O)=O)=C(OC)C=C4[C@@]3([H])CC[C@]12C",
        "id": "DB07596",
        "molecule": "(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",
        "iupac_name": "(1R,3aS,3bS,9bS,11aR)-1-(cyanomethyl)-8-methoxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-yl sulfamate",
        "inchi": {
            "hash": "NTSPHKOMJMBWOU-NNKXXINSSA-N",
            "id": "InChI=1S/C21H28N2O4S/c1-21-9-7-15-16(18(21)6-4-14(21)8-10-22)5-3-13-11-20(27-28(23,24)25)19(26-2)12-17(13)15/h11-12,14-16,18H,3-9H2,1-2H3,(H2,23,24,25)/t14-,15+,16-,18+,21-/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 404.523,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 404.176978084,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton.",
        "link": "https://go.drugbank.com/drugs/DB07596",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UCarbonic anhydrase 2"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "OC(CC1=CC=CC(=C1)C1=CC=C(C=C1)C1=CC=CC=C1)(P(O)(O)=O)P(O)(O)=O",
        "id": "DB07409",
        "molecule": "(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",
        "iupac_name": "(1-hydroxy-2-{4'-phenyl-[1,1'-biphenyl]-3-yl}-1-phosphonoethyl)phosphonic acid",
        "inchi": {
            "hash": "MPBUFKZCEBTBSK-UHFFFAOYSA-N",
            "id": "InChI=1S/C20H20O7P2/c21-20(28(22,23)24,29(25,26)27)14-15-5-4-8-19(13-15)18-11-9-17(10-12-18)16-6-2-1-3-7-16/h1-13,21H,14H2,(H2,22,23,24)(H2,25,26,27)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 434.3161,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 434.068426018,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as p-terphenyls. These are terphenyls with a structure containing the 1,4-diphenylbenzene skeleton.",
        "link": "https://go.drugbank.com/drugs/DB07409",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Escherichia coli (strain K12)",
                "target": "UDitrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@]1(N(C(C)=O)C2=CC=CC(O)=C2NC2=C1C(=O)CC(C)(C)C2)C1=C(Cl)C=C(Cl)C=C1",
        "id": "DB08747",
        "molecule": "(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",
        "iupac_name": "(10R)-9-acetyl-10-(2,4-dichlorophenyl)-4-hydroxy-14,14-dimethyl-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7-tetraen-12-one",
        "inchi": {
            "hash": "JJTPPGUNMJMPLY-QFIPXVFZSA-N",
            "id": "InChI=1S/C23H22Cl2N2O3/c1-12(28)27-17-5-4-6-18(29)21(17)26-16-10-23(2,3)11-19(30)20(16)22(27)14-8-7-13(24)9-15(14)25/h4-9,22,26,29H,10-11H2,1-3H3/t22-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 445.338,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 444.100747994,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms).",
        "link": "https://go.drugbank.com/drugs/DB08747",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "",
                "target": "UGenome polyprotein"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC\\C=C/C\\C=C/C[C@@H](O)\\C=C\\C=C/C\\C=C/CCCC(O)=O",
        "id": "DB15571",
        "molecule": "(12R)-12-hydroxyeicosapentaenoic acid",
        "cas": "109430-12-8",
        "iupac_name": "(5Z,8Z,10E,12R,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid",
        "inchi": {
            "hash": "MCRJLMXYVFDXLS-IHWYZUJNSA-N",
            "id": "InChI=1S/C20H30O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h3-4,7-11,13-14,17,19,21H,2,5-6,12,15-16,18H2,1H3,(H,22,23)/b4-3-,9-7-,11-8-,13-10-,17-14+/t19-/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 318.457,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 318.219494826,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB15571",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@]1(C2CCN(CC2)S(C)(=O)=O)C2=C(C=C(Cl)C=C2)C(=CC2=C1N=CC=C2)N1CCNCC1",
        "id": "DB07216",
        "molecule": "(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",
        "iupac_name": "(2S)-13-chloro-2-(1-methanesulfonylpiperidin-4-yl)-10-(piperazin-1-yl)-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene",
        "inchi": {
            "hash": "ZMGCFGGMTCMSDP-QHCPKHFHSA-N",
            "id": "InChI=1S/C24H29ClN4O2S/c1-32(30,31)29-11-6-17(7-12-29)23-20-5-4-19(25)16-21(20)22(28-13-9-26-10-14-28)15-18-3-2-8-27-24(18)23/h2-5,8,15-17,23,26H,6-7,9-14H2,1H3/t23-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 473.031,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 472.169974589,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as benzocycloheptapyridines. These are aromatic compounds containing a benzene ring and a pyridine ring fused to a seven membered carbocycle.",
        "link": "https://go.drugbank.com/drugs/DB07216",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha"
            },
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UProtein farnesyltransferase subunit beta"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H]C(C)(O)COC(=O)O[C@]1([H])C[C@]([H])(C)CC[C@@]1([H])C(C)C",
        "id": "DB14136",
        "molecule": "(-)-menthol 1-propylene glycol carbonate",
        "cas": "260781-16-6",
        "iupac_name": "1-[({[(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl]oxy}carbonyl)oxy]propan-2-ol",
        "inchi": {
            "hash": "FLYJSXDJKBHQAU-IBSWDFHHSA-N",
            "id": "InChI=1S/C14H26O4/c1-9(2)12-6-5-10(3)7-13(12)18-14(16)17-8-11(4)15/h9-13,15H,5-8H2,1-4H3/t10-,11?,12+,13-/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 258.358,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 258.183109317,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB14136",
        "type": "Small Molecule",
        "synonyms": [
            "(-)-menthol (+/-)-1-propylene glycol carbonate",
            "2-hydroxypropyl ((1R",
            "2S",
            "5R)-2-isopropyl-5-methyl-cyclohexyl) carbonate",
            "Carbonic acid",
            "2-hydroxypropyl (1R",
            "2S",
            "5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester",
            "Fema no. 3806",
            "1-propylene glycol carbonate"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CCCCCCCCC(O)(P(O)(O)=O)P(O)(O)=O",
        "id": "DB06931",
        "molecule": "(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",
        "iupac_name": "(1-hydroxy-1-phosphonononyl)phosphonic acid",
        "inchi": {
            "hash": "COHUUYPEYRMWTH-UHFFFAOYSA-N",
            "id": "InChI=1S/C9H22O7P2/c1-2-3-4-5-6-7-8-9(10,17(11,12)13)18(14,15)16/h10H,2-8H2,1H3,(H2,11,12,13)(H2,14,15,16)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 304.2143,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 304.084076082,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms.",
        "link": "https://go.drugbank.com/drugs/DB06931",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGeranylgeranyl pyrophosphate synthase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CCCCC\\C=C/C=C/CCCCCCCCC(O)=O",
        "id": "DB04746",
        "molecule": "(10E,12Z)-octadecadienoic acid",
        "cas": "2420-56-6",
        "iupac_name": "(10E,12Z)-octadeca-10,12-dienoic acid",
        "inchi": {
            "hash": "GKJZMAHZJGSBKD-NMMTYZSQSA-N",
            "id": "InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-9H,2-5,10-17H2,1H3,(H,19,20)/b7-6-,9-8+"
        },
        "weight": [
            {
                "type": "average",
                "weight": 280.4455,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 280.240230268,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions.",
        "link": "https://go.drugbank.com/drugs/DB04746",
        "type": "Small Molecule",
        "synonyms": [
            "(10E",
            "12Z)-octadeca-10",
            "12-dienoic acid",
            "(E",
            "Z)-octadeca-10",
            "12-dienoic acid",
            "10-trans-12-cis-CLA",
            "10-trans-12-cis-conjugated linoleic acid",
            "10-trans-12-cis-linoleic acid",
            "10-trans-12-cis-octadecadienoic acid",
            "10",
            "12-trans",
            "cis-octadecanoic acid",
            "C18:2",
            "n-6",
            "8 cis",
            "trans"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Propionibacterium acnes",
                "target": "UPutative aminooxidase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "ON1CCCC(C1=O)P(O)(O)=O",
        "id": "DB17108",
        "molecule": "(1-Hydroxy-2-oxopiperidin-3-yl)phosphonic acid",
        "cas": "2004714-32-1",
        "iupac_name": "(1-hydroxy-2-oxopiperidin-3-yl)phosphonic acid",
        "inchi": {
            "hash": "DVZQUMSQEGOYMX-UHFFFAOYSA-N",
            "id": "InChI=1S/C5H10NO5P/c7-5-4(12(9,10)11)2-1-3-6(5)8/h4,8H,1-3H2,(H2,9,10,11)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 195.111,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 195.029659424,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB17108",
        "type": "Small Molecule",
        "synonyms": [
            "Phosphonic acid",
            "p-(1-hydroxy-2-oxo-3-piperidinyl)-"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "C[C@H](C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1",
        "id": "DB02047",
        "molecule": "(+)-2-(4-biphenyl)propionic acid",
        "cas": "10532-14-6",
        "iupac_name": "(2S)-2-{[1,1'-biphenyl]-4-yl}propanoic acid",
        "inchi": {
            "hash": "JALUUBQFLPUJMY-NSHDSACASA-N",
            "id": "InChI=1S/C15H14O2/c1-11(15(16)17)12-7-9-14(10-8-12)13-5-3-2-4-6-13/h2-11H,1H3,(H,16,17)/t11-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 226.2705,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 226.099379692,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond.",
        "link": "https://go.drugbank.com/drugs/DB02047",
        "type": "Small Molecule",
        "synonyms": [
            "(2S)-2-(4-Biphenylyl)propanoic acid",
            "2-(1",
            "1'-biphenyl-4-yl)propanoic acid"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UProstaglandin G/H synthase 1"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC(C)[C@H]1CC[C@H](C)C[C@@H]1O",
        "id": "DB11344",
        "molecule": "(+)-menthol",
        "cas": "15356-60-2",
        "iupac_name": "(1S,2R,5S)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol",
        "inchi": {
            "hash": "NOOLISFMXDJSKH-AEJSXWLSSA-N",
            "id": "InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 156.269,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 156.151415264,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as menthane monoterpenoids. These are monoterpenoids with a structure based on the o-, m-, or p-menthane backbone. P-menthane consists of the cyclohexane ring with a methyl group and a (2-methyl)-propyl group at the 1 and 4 ring position, respectively. The o- and m- menthanes are much rarer, and presumably arise by alkyl migration of p-menthanes.",
        "link": "https://go.drugbank.com/drugs/DB11344",
        "type": "Small Molecule",
        "synonyms": [
            "(+)-(1S",
            "2R",
            "5S)-menthol",
            "(+)-(1S",
            "3S",
            "4R)-menthol",
            "(1S",
            "2R",
            "5S)-(+)-menthol",
            "(1S",
            "2R",
            "5S)-menthol",
            "D-menthol"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CCCCCCC(O)(P(O)(O)=O)P(O)(O)=O",
        "id": "DB06830",
        "molecule": "(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",
        "iupac_name": "(1-hydroxy-1-phosphonoheptyl)phosphonic acid",
        "inchi": {
            "hash": "IJEGNOYPWRBKAE-UHFFFAOYSA-N",
            "id": "InChI=1S/C7H18O7P2/c1-2-3-4-5-6-7(8,15(9,10)11)16(12,13)14/h8H,2-6H2,1H3,(H2,9,10,11)(H2,12,13,14)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 276.1611,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 276.052775954,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms.",
        "link": "https://go.drugbank.com/drugs/DB06830",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGeranylgeranyl pyrophosphate synthase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@@H](C1)C(C)=C",
        "id": "DB18097",
        "molecule": "(-)-beta-Elemene",
        "cas": "515-13-9",
        "inchi": {
            "hash": "OPFTUNCRGUEPRZ-QLFBSQMISA-N",
            "id": "InChI=1S/C15H24/c1-7-15(6)9-8-13(11(2)3)10-14(15)12(4)5/h7,13-14H,1-2,4,8-10H2,3,5-6H3/t13-,14+,15+/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 204.357,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 204.187800773,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB18097",
        "type": "Small Molecule",
        "synonyms": [
            ".beta.-elemene",
            "(-)-.beta.-elemene",
            "(-)-B-elemene",
            "(-)-beta-Elemene",
            "Cyclohexane",
            "1-ethenyl-1-methyl-2",
            "4-bis(1-methylethenyl)-",
            "(1s",
            "2s",
            "4r)-",
            "Elemene",
            "(-)-.beta.-"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H]N([H])C1=NC(=O)C2=C(C=CC(C[C@@H](C(O)=O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H]",
        "id": "DB04264",
        "molecule": "(10R)-10-formyl-5,8,10-trideazafolic acid",
        "iupac_name": "(2S)-2-({4-[(1R)-2-(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)-1-carboxyethyl]phenyl}formamido)pentanedioic acid",
        "inchi": {
            "hash": "DAOQLLQRJAXMGY-PBHICJAKSA-N",
            "id": "InChI=1S/C23H22N4O8/c24-23-26-16-6-1-11(10-15(16)20(31)27-23)9-14(21(32)33)12-2-4-13(5-3-12)19(30)25-17(22(34)35)7-8-18(28)29/h1-6,10,14,17H,7-9H2,(H,25,30)(H,28,29)(H,32,33)(H,34,35)(H3,24,26,27,31)/t14-,17+/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 482.4428,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 482.1437637,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.",
        "link": "https://go.drugbank.com/drugs/DB04264",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Escherichia coli (strain K12)",
                "target": "UPhosphoribosylglycinamide formyltransferase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "C[C@H](C(O)=O)C1=CC=C(C=C1)C1=CC=CC=C1",
        "id": "DB02047",
        "molecule": "(+)-2-(4-biphenyl)propionic acid",
        "cas": "10532-14-6",
        "iupac_name": "(2S)-2-{[1,1'-biphenyl]-4-yl}propanoic acid",
        "inchi": {
            "hash": "JALUUBQFLPUJMY-NSHDSACASA-N",
            "id": "InChI=1S/C15H14O2/c1-11(15(16)17)12-7-9-14(10-8-12)13-5-3-2-4-6-13/h2-11H,1H3,(H,16,17)/t11-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 226.2705,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 226.099379692,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond.",
        "link": "https://go.drugbank.com/drugs/DB02047",
        "type": "Small Molecule",
        "synonyms": [
            "(2S)-2-(4-Biphenylyl)propanoic acid",
            "2-(1",
            "1'-biphenyl-4-yl)propanoic acid"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UProstaglandin G/H synthase 1"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "COC1=CC2=C(C=C1)N(CC1=CC=CC=C1)C(C)=C2CC(O)=O",
        "id": "DB03121",
        "molecule": "(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid",
        "cas": "59283-35-1",
        "iupac_name": "2-(1-benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid",
        "inchi": {
            "hash": "ZEKCBTQHDTUHRJ-UHFFFAOYSA-N",
            "id": "InChI=1S/C19H19NO3/c1-13-16(11-19(21)22)17-10-15(23-2)8-9-18(17)20(13)12-14-6-4-3-5-7-14/h3-10H,11-12H2,1-2H3,(H,21,22)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 309.3591,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 309.136493479,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole.",
        "link": "https://go.drugbank.com/drugs/DB03121",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UPhospholipase A2, membrane associated"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC[C@@H](C1=CC(NC(=O)CNC(=O)OC(C)(C)C)=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O",
        "id": "DB08664",
        "molecule": "({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester",
        "iupac_name": "tert-butyl N-[({3-[(1S)-1-(4-hydroxy-2-oxo-2H-chromen-3-yl)propyl]phenyl}carbamoyl)methyl]carbamate",
        "inchi": {
            "hash": "QUQQVMVIWCUYFV-KRWDZBQOSA-N",
            "id": "InChI=1S/C25H28N2O6/c1-5-17(21-22(29)18-11-6-7-12-19(18)32-23(21)30)15-9-8-10-16(13-15)27-20(28)14-26-24(31)33-25(2,3)4/h6-13,17,29H,5,14H2,1-4H3,(H,26,31)(H,27,28)/t17-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 452.4996,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 452.194736638,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as 4-hydroxycoumarins. These are coumarins that contain one or more hydroxyl groups attached to C4-position the coumarin skeleton.",
        "link": "https://go.drugbank.com/drugs/DB08664",
        "type": "Small Molecule",
        "synonyms": [
            "tert-butyl N-[({3-[(1S)-1-(4-hydroxy-2-oxo-2H-chromen-3-yl)propyl]phenyl}carbamoyl)methyl]carbamate"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "HIV-2",
                "target": "UGag-Pol polyprotein"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "O\\N=C1/CCC2=CC(=CC=C12)C1=CN(N=C1C1=CC=NC=C1)C1CCNCC1",
        "id": "DB08553",
        "molecule": "(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",
        "iupac_name": "N-[(1E)-5-[1-(piperidin-4-yl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl]-2,3-dihydro-1H-inden-1-ylidene]hydroxylamine",
        "background": "(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1h-pyrazol-4-yl)-2,3-dihydro-1h-inden-1-one oxime is a solid. This compound belongs to the phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. It targets the protein serine/threonine-protein kinase B-raf.\n",
        "inchi": {
            "hash": "KWEFZSZCLBHIEQ-YYADALCUSA-N",
            "id": "InChI=1S/C22H23N5O/c28-26-21-4-2-16-13-17(1-3-19(16)21)20-14-27(18-7-11-24-12-8-18)25-22(20)15-5-9-23-10-6-15/h1,3,5-6,9-10,13-14,18,24,28H,2,4,7-8,11-12H2/b26-21+"
        },
        "weight": [
            {
                "type": "average",
                "weight": 373.4509,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 373.190260383,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as indanes. These are compounds containing an indane moiety, which consists of a cyclopentane fused to a benzene ring.",
        "link": "https://go.drugbank.com/drugs/DB08553",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "USerine/threonine-protein kinase B-raf"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC(C)(O)[C@@H]1CC2=C(O1)C=C1OC(=O)C(=CC1=C2)C(C)(C)C=C",
        "id": "DB02205",
        "molecule": "(+)-Rutamarin alcohol",
        "cas": "14755-47-6",
        "iupac_name": "(2S)-2-(2-hydroxypropan-2-yl)-6-(2-methylbut-3-en-2-yl)-2H,3H,7H-furo[3,2-g]chromen-7-one",
        "inchi": {
            "hash": "JCDLLLXYAICSQV-INIZCTEOSA-N",
            "id": "InChI=1S/C19H22O4/c1-6-18(2,3)13-8-11-7-12-9-16(19(4,5)21)22-14(12)10-15(11)23-17(13)20/h6-8,10,16,21H,1,9H2,2-5H3/t16-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 314.3756,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 314.151809192,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as psoralens. These are organic compounds containing a psoralen moiety, which consists of a furan fused to a chromenone to for 7H-furo[3,2-g]chromen-7-one.",
        "link": "https://go.drugbank.com/drugs/DB02205",
        "type": "Small Molecule",
        "synonyms": [
            "(+)-Chalepin"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGlyceraldehyde-3-phosphate dehydrogenase, testis-specific"
            },
            {
                "action": "Not Available",
                "organism": "Trypanosoma cruzi",
                "target": "UGlyceraldehyde-3-phosphate dehydrogenase, glycosomal"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H]N([H])C1=NC(=O)C2=C(C=CC(C[C@@H](C(O)=O)C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)=C2)N1[H]",
        "id": "DB04264",
        "molecule": "(10R)-10-formyl-5,8,10-trideazafolic acid",
        "iupac_name": "(2S)-2-({4-[(1R)-2-(2-amino-4-oxo-1,4-dihydroquinazolin-6-yl)-1-carboxyethyl]phenyl}formamido)pentanedioic acid",
        "inchi": {
            "hash": "DAOQLLQRJAXMGY-PBHICJAKSA-N",
            "id": "InChI=1S/C23H22N4O8/c24-23-26-16-6-1-11(10-15(16)20(31)27-23)9-14(21(32)33)12-2-4-13(5-3-12)19(30)25-17(22(34)35)7-8-18(28)29/h1-6,10,14,17H,7-9H2,(H,25,30)(H,28,29)(H,32,33)(H,34,35)(H3,24,26,27,31)/t14-,17+/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 482.4428,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 482.1437637,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.",
        "link": "https://go.drugbank.com/drugs/DB04264",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Escherichia coli (strain K12)",
                "target": "UPhosphoribosylglycinamide formyltransferase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@]1(C2CCN(CC2)S(C)(=O)=O)C2=C(C=C(Cl)C=C2)C(=CC2=C1N=CC=C2)N1CCNCC1",
        "id": "DB07216",
        "molecule": "(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",
        "iupac_name": "(2S)-13-chloro-2-(1-methanesulfonylpiperidin-4-yl)-10-(piperazin-1-yl)-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene",
        "inchi": {
            "hash": "ZMGCFGGMTCMSDP-QHCPKHFHSA-N",
            "id": "InChI=1S/C24H29ClN4O2S/c1-32(30,31)29-11-6-17(7-12-29)23-20-5-4-19(25)16-21(20)22(28-13-9-26-10-14-28)15-18-3-2-8-27-24(18)23/h2-5,8,15-17,23,26H,6-7,9-14H2,1H3/t23-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 473.031,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 472.169974589,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as benzocycloheptapyridines. These are aromatic compounds containing a benzene ring and a pyridine ring fused to a seven membered carbocycle.",
        "link": "https://go.drugbank.com/drugs/DB07216",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha"
            },
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UProtein farnesyltransferase subunit beta"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "OC(=O)CO\\N=C1/C2=CC=CCC2=N/C/1=C1\\C(=O)N=C2CC=CC=C12",
        "id": "DB07949",
        "molecule": "({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid",
        "iupac_name": "2-({[(Z,3E)-2'-oxo-3,7-dihydro-2'H,7'H-[2,3'-biindolyliden]-3-ylidene]amino}oxy)acetic acid",
        "inchi": {
            "hash": "BFQRPTKOSYMPOL-LALPNIDTSA-N",
            "id": "InChI=1S/C18H13N3O4/c22-14(23)9-25-21-16-11-6-2-4-8-13(11)19-17(16)15-10-5-1-3-7-12(10)20-18(15)24/h1-6H,7-9H2,(H,22,23)/b17-15-,21-16+"
        },
        "weight": [
            {
                "type": "average",
                "weight": 335.3135,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 335.090605919,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring.",
        "link": "https://go.drugbank.com/drugs/DB07949",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGlycogen phosphorylase, muscle form"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CCCCC\\C=C/C=C/CCCCCCCCC(O)=O",
        "id": "DB04746",
        "molecule": "(10E,12Z)-octadecadienoic acid",
        "cas": "2420-56-6",
        "iupac_name": "(10E,12Z)-octadeca-10,12-dienoic acid",
        "inchi": {
            "hash": "GKJZMAHZJGSBKD-NMMTYZSQSA-N",
            "id": "InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-9H,2-5,10-17H2,1H3,(H,19,20)/b7-6-,9-8+"
        },
        "weight": [
            {
                "type": "average",
                "weight": 280.4455,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 280.240230268,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions.",
        "link": "https://go.drugbank.com/drugs/DB04746",
        "type": "Small Molecule",
        "synonyms": [
            "(10E",
            "12Z)-octadeca-10",
            "12-dienoic acid",
            "(E",
            "Z)-octadeca-10",
            "12-dienoic acid",
            "10-trans-12-cis-CLA",
            "10-trans-12-cis-conjugated linoleic acid",
            "10-trans-12-cis-linoleic acid",
            "10-trans-12-cis-octadecadienoic acid",
            "10",
            "12-trans",
            "cis-octadecanoic acid",
            "C18:2",
            "n-6",
            "8 cis",
            "trans"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Propionibacterium acnes",
                "target": "UPutative aminooxidase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "C[C@H](O)CBr",
        "id": "DB03335",
        "molecule": "(+)-1-bromo-2-propanol",
        "cas": "16088-60-1",
        "iupac_name": "(2S)-1-bromopropan-2-ol",
        "inchi": {
            "hash": "WEGOLYBUWCMMMY-VKHMYHEASA-N",
            "id": "InChI=1S/C3H7BrO/c1-3(5)2-4/h3,5H,2H2,1H3/t3-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 138.991,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 137.968027493,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as bromohydrins. These are alcohols substituted by a bromine atom at a saturated carbon atom otherwise bearing only hydrogen or hydrocarbyl groups.",
        "link": "https://go.drugbank.com/drugs/DB03335",
        "type": "Small Molecule",
        "synonyms": [
            "(S)-(+)-1-Bromo-2-propanol"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Pseudomonas paucimobilis",
                "target": "UHaloalkane dehalogenase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@]12CN(CCN3NC4=C(C=CC=C4C3=O)C3=NC4=C(NC3=O)C=CC=C4O1)[C@]([H])(C)C2",
        "id": "DB06888",
        "molecule": "(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",
        "iupac_name": "(13R,15S)-13-methyl-16-oxa-8,9,12,22,24-pentaazahexacyclo[15.6.2.1^{6,9}.1^{12,15}.0^{2,7}.0^{21,25}]heptacosa-1(24),2(7),3,5,17,19,21(25)-heptaene-23,27-dione",
        "inchi": {
            "hash": "KBLPHMRCKHFBJB-OLZOCXBDSA-N",
            "id": "InChI=1S/C22H21N5O3/c1-12-10-13-11-26(12)8-9-27-22(29)15-5-2-4-14(18(15)25-27)19-21(28)23-16-6-3-7-17(30-13)20(16)24-19/h2-7,12-13,25H,8-11H2,1H3,(H,23,28)/t12-,13+/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 403.4338,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 403.164439563,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as quinoxalines. These are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring.",
        "link": "https://go.drugbank.com/drugs/DB06888",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UCyclin-dependent kinase 2"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CCCCCCC(O)(P(O)(O)=O)P(O)(O)=O",
        "id": "DB06830",
        "molecule": "(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",
        "iupac_name": "(1-hydroxy-1-phosphonoheptyl)phosphonic acid",
        "inchi": {
            "hash": "IJEGNOYPWRBKAE-UHFFFAOYSA-N",
            "id": "InChI=1S/C7H18O7P2/c1-2-3-4-5-6-7(8,15(9,10)11)16(12,13)14/h8H,2-6H2,1H3,(H2,9,10,11)(H2,12,13,14)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 276.1611,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 276.052775954,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms.",
        "link": "https://go.drugbank.com/drugs/DB06830",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGeranylgeranyl pyrophosphate synthase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C([3H])C([3H])C2=CC(=O)C([3H])C([3H])[C@]12C",
        "id": "DB14093",
        "molecule": "(1,2,6,7-3H)Testosterone",
        "cas": "67308-98-9",
        "iupac_name": "(1S,3aS,3bR,9aR,9bS,11aS)-1-hydroxy-9a,11a-dimethyl(4,5,8,9-3H4)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one",
        "inchi": {
            "hash": "MUMGGOZAMZWBJJ-JQSYSRDDSA-N",
            "id": "InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1/i3T,4T,7T,9T/t3?,4?,7?,9?,14-,15-,16-,17-,18-,19-"
        },
        "weight": [
            {
                "type": "average",
                "weight": 296.463,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 296.241827085,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB14093",
        "type": "Small Molecule",
        "synonyms": [
            "Testosterone",
            "1",
            "2",
            "6",
            "7-H-3"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\nAbciximab(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Abciximab.Acenocoumarol(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Acenocoumarol.Alteplase(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Alteplase.Ancrod(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Ancrod.Anistreplase(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Anistreplase.Antithrombin Alfa(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Antithrombin Alfa.Antithrombin III human(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Antithrombin III human.Apixaban(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Apixaban.Ardeparin(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Ardeparin.Argatroban(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Argatroban.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   "
    },
    {
        "smiles": "[H]C(C)(O)COC(=O)O[C@]1([H])C[C@]([H])(C)CC[C@@]1([H])C(C)C",
        "id": "DB14136",
        "molecule": "(-)-menthol 1-propylene glycol carbonate",
        "cas": "260781-16-6",
        "iupac_name": "1-[({[(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl]oxy}carbonyl)oxy]propan-2-ol",
        "inchi": {
            "hash": "FLYJSXDJKBHQAU-IBSWDFHHSA-N",
            "id": "InChI=1S/C14H26O4/c1-9(2)12-6-5-10(3)7-13(12)18-14(16)17-8-11(4)15/h9-13,15H,5-8H2,1-4H3/t10-,11?,12+,13-/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 258.358,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 258.183109317,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB14136",
        "type": "Small Molecule",
        "synonyms": [
            "(-)-menthol (+/-)-1-propylene glycol carbonate",
            "2-hydroxypropyl ((1R",
            "2S",
            "5R)-2-isopropyl-5-methyl-cyclohexyl) carbonate",
            "Carbonic acid",
            "2-hydroxypropyl (1R",
            "2S",
            "5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester",
            "Fema no. 3806",
            "1-propylene glycol carbonate"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC(C)(O)[C@@H]1CC2=C(O1)C=C1OC(=O)C(=CC1=C2)C(C)(C)C=C",
        "id": "DB02205",
        "molecule": "(+)-Rutamarin alcohol",
        "cas": "14755-47-6",
        "iupac_name": "(2S)-2-(2-hydroxypropan-2-yl)-6-(2-methylbut-3-en-2-yl)-2H,3H,7H-furo[3,2-g]chromen-7-one",
        "inchi": {
            "hash": "JCDLLLXYAICSQV-INIZCTEOSA-N",
            "id": "InChI=1S/C19H22O4/c1-6-18(2,3)13-8-11-7-12-9-16(19(4,5)21)22-14(12)10-15(11)23-17(13)20/h6-8,10,16,21H,1,9H2,2-5H3/t16-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 314.3756,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 314.151809192,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as psoralens. These are organic compounds containing a psoralen moiety, which consists of a furan fused to a chromenone to for 7H-furo[3,2-g]chromen-7-one.",
        "link": "https://go.drugbank.com/drugs/DB02205",
        "type": "Small Molecule",
        "synonyms": [
            "(+)-Chalepin"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGlyceraldehyde-3-phosphate dehydrogenase, testis-specific"
            },
            {
                "action": "Not Available",
                "organism": "Trypanosoma cruzi",
                "target": "UGlyceraldehyde-3-phosphate dehydrogenase, glycosomal"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@]1(N(C(C)=O)C2=CC=CC(O)=C2NC2=C1C(=O)CC(C)(C)C2)C1=C(Cl)C=C(Cl)C=C1",
        "id": "DB08747",
        "molecule": "(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",
        "iupac_name": "(10R)-9-acetyl-10-(2,4-dichlorophenyl)-4-hydroxy-14,14-dimethyl-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7-tetraen-12-one",
        "inchi": {
            "hash": "JJTPPGUNMJMPLY-QFIPXVFZSA-N",
            "id": "InChI=1S/C23H22Cl2N2O3/c1-12(28)27-17-5-4-6-18(29)21(17)26-16-10-23(2,3)11-19(30)20(16)22(27)14-8-7-13(24)9-15(14)25/h4-9,22,26,29H,10-11H2,1-3H3/t22-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 445.338,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 444.100747994,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms).",
        "link": "https://go.drugbank.com/drugs/DB08747",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "",
                "target": "UGenome polyprotein"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@]12CN(CCN3NC4=C(C=CC=C4C3=O)C3=NC4=C(NC3=O)C=CC=C4O1)[C@]([H])(C)C2",
        "id": "DB06888",
        "molecule": "(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",
        "iupac_name": "(13R,15S)-13-methyl-16-oxa-8,9,12,22,24-pentaazahexacyclo[15.6.2.1^{6,9}.1^{12,15}.0^{2,7}.0^{21,25}]heptacosa-1(24),2(7),3,5,17,19,21(25)-heptaene-23,27-dione",
        "inchi": {
            "hash": "KBLPHMRCKHFBJB-OLZOCXBDSA-N",
            "id": "InChI=1S/C22H21N5O3/c1-12-10-13-11-26(12)8-9-27-22(29)15-5-2-4-14(18(15)25-27)19-21(28)23-16-6-3-7-17(30-13)20(16)24-19/h2-7,12-13,25H,8-11H2,1H3,(H,23,28)/t12-,13+/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 403.4338,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 403.164439563,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as quinoxalines. These are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring.",
        "link": "https://go.drugbank.com/drugs/DB06888",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UCyclin-dependent kinase 2"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "NC1=NC=NC2=C1N=CN2[C@@H]1C=C[C@H](O)[C@H]1O",
        "id": "DB03216",
        "molecule": "(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine",
        "iupac_name": "(1S,2S,5R)-5-(6-amino-9H-purin-9-yl)cyclopent-3-ene-1,2-diol",
        "inchi": {
            "hash": "RQPALADHFYHEHK-CHKWXVPMSA-N",
            "id": "InChI=1S/C10H11N5O2/c11-9-7-10(13-3-12-9)15(4-14-7)5-1-2-6(16)8(5)17/h1-6,8,16-17H,(H2,11,12,13)/t5-,6+,8+/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 233.2266,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 233.091274621,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as 1,3-substituted cyclopentyl purine nucleosides. These are nucleoside analogues with a structure that consists of a cyclobutane that is substituted a the 1-position with a hydroxyl group and at the 3-position with either a purine base.",
        "link": "https://go.drugbank.com/drugs/DB03216",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UAdenosylhomocysteinase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "ON1CCCC(C1=O)P(O)(O)=O",
        "id": "DB17108",
        "molecule": "(1-Hydroxy-2-oxopiperidin-3-yl)phosphonic acid",
        "cas": "2004714-32-1",
        "iupac_name": "(1-hydroxy-2-oxopiperidin-3-yl)phosphonic acid",
        "inchi": {
            "hash": "DVZQUMSQEGOYMX-UHFFFAOYSA-N",
            "id": "InChI=1S/C5H10NO5P/c7-5-4(12(9,10)11)2-1-3-6(5)8/h4,8H,1-3H2,(H2,9,10,11)"
        },
        "weight": [
            {
                "type": "average",
                "weight": 195.111,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 195.029659424,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB17108",
        "type": "Small Molecule",
        "synonyms": [
            "Phosphonic acid",
            "p-(1-hydroxy-2-oxo-3-piperidinyl)-"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "OC(=O)CO\\N=C1/C2=CC=CCC2=N/C/1=C1\\C(=O)N=C2CC=CC=C12",
        "id": "DB07949",
        "molecule": "({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid",
        "iupac_name": "2-({[(Z,3E)-2'-oxo-3,7-dihydro-2'H,7'H-[2,3'-biindolyliden]-3-ylidene]amino}oxy)acetic acid",
        "inchi": {
            "hash": "BFQRPTKOSYMPOL-LALPNIDTSA-N",
            "id": "InChI=1S/C18H13N3O4/c22-14(23)9-25-21-16-11-6-2-4-8-13(11)19-17(16)15-10-5-1-3-7-12(10)20-18(15)24/h1-6H,7-9H2,(H,22,23)/b17-15-,21-16+"
        },
        "weight": [
            {
                "type": "average",
                "weight": 335.3135,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 335.090605919,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring.",
        "link": "https://go.drugbank.com/drugs/DB07949",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UGlycogen phosphorylase, muscle form"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@]1(CC#N)CC[C@@]2([H])[C@]3([H])CCC4=CC(OS(N)(=O)=O)=C(OC)C=C4[C@@]3([H])CC[C@]12C",
        "id": "DB07596",
        "molecule": "(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",
        "iupac_name": "(1R,3aS,3bS,9bS,11aR)-1-(cyanomethyl)-8-methoxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-yl sulfamate",
        "inchi": {
            "hash": "NTSPHKOMJMBWOU-NNKXXINSSA-N",
            "id": "InChI=1S/C21H28N2O4S/c1-21-9-7-15-16(18(21)6-4-14(21)8-10-22)5-3-13-11-20(27-28(23,24)25)19(26-2)12-17(13)15/h11-12,14-16,18H,3-9H2,1-2H3,(H2,23,24,25)/t14-,15+,16-,18+,21-/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 404.523,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 404.176978084,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton.",
        "link": "https://go.drugbank.com/drugs/DB07596",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UCarbonic anhydrase 2"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "CC\\C=C/C\\C=C/C[C@@H](O)\\C=C\\C=C/C\\C=C/CCCC(O)=O",
        "id": "DB15571",
        "molecule": "(12R)-12-hydroxyeicosapentaenoic acid",
        "cas": "109430-12-8",
        "iupac_name": "(5Z,8Z,10E,12R,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid",
        "inchi": {
            "hash": "MCRJLMXYVFDXLS-IHWYZUJNSA-N",
            "id": "InChI=1S/C20H30O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h3-4,7-11,13-14,17,19,21H,2,5-6,12,15-16,18H2,1H3,(H,22,23)/b4-3-,9-7-,11-8-,13-10-,17-14+/t19-/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 318.457,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 318.219494826,
                "units": "Da"
            }
        ],
        "link": "https://go.drugbank.com/drugs/DB15571",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "is_stub": true,
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "C[C@H](O)CBr",
        "id": "DB03335",
        "molecule": "(+)-1-bromo-2-propanol",
        "cas": "16088-60-1",
        "iupac_name": "(2S)-1-bromopropan-2-ol",
        "inchi": {
            "hash": "WEGOLYBUWCMMMY-VKHMYHEASA-N",
            "id": "InChI=1S/C3H7BrO/c1-3(5)2-4/h3,5H,2H2,1H3/t3-/m0/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 138.991,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 137.968027493,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as bromohydrins. These are alcohols substituted by a bromine atom at a saturated carbon atom otherwise bearing only hydrogen or hydrocarbyl groups.",
        "link": "https://go.drugbank.com/drugs/DB03335",
        "type": "Small Molecule",
        "synonyms": [
            "(S)-(+)-1-Bromo-2-propanol"
        ],
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Pseudomonas paucimobilis",
                "target": "UHaloalkane dehalogenase"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    },
    {
        "smiles": "[H][C@@]1(C)CNC2=C(SC3=C2C2=C(C=C3)N=C(C=C2)C2=CN=C(C)C=C2)C(=O)N1",
        "id": "DB07430",
        "molecule": "(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",
        "iupac_name": "(15R)-15-methyl-5-(6-methylpyridin-3-yl)-11-thia-6,14,17-triazatetracyclo[8.8.0.0^{2,7}.0^{12,18}]octadeca-1(10),2(7),3,5,8,12(18)-hexaen-13-one",
        "inchi": {
            "hash": "CMWRPDHVGMHLSZ-GFCCVEGCSA-N",
            "id": "InChI=1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1"
        },
        "weight": [
            {
                "type": "average",
                "weight": 374.459,
                "units": "Da"
            },
            {
                "type": "monoisotopic",
                "weight": 374.120131908,
                "units": "Da"
            }
        ],
        "description": "This compound belongs to the class of organic compounds known as bipyridines and oligopyridines. These are organic compounds containing two pyridine rings linked to each other.",
        "link": "https://go.drugbank.com/drugs/DB07430",
        "type": "Small Molecule",
        "indication": "Not AvailableReduce drug development failure ratesBuild, train, \u0026 validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, \u0026 validate predictive machine-learning models with structured datasets.See how",
        "moa": [
            {
                "action": "Not Available",
                "organism": "Humans",
                "target": "UMAP kinase-activated protein kinase 2"
            }
        ],
        "adverse_effects": "Improve decision support \u0026 research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning \u0026 precautions, \u0026 incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support \u0026 research outcomes with our structured adverse effects data.See a data sample",
        "drug_interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not Available"
    }
]